Code of Federal Regulations (Last Updated: October 10, 2024) |
Title 21 - Food and Drugs |
Chapter I - Food and Drug Administration, Department of Health and Human Services |
SubChapter F - Biologics |
Part 640 - Additional Standards for Human Blood and Blood Products |
Subpart J - Immune Globulin (Human) |
§ 640.103 - The final product.
Latest version.
-
§ 640.103 The final product.
(a) Final solution. The final product shall be a 16.5 ±1.5 percent solution of globulin containing 0.3 molar glycine and a preservative.
(b) Protein composition. At least 96 percent of the total protein shall be immunoglobulin G (IgG), as determined by a method that has been approved for each manufacturer by the Director, Center for Biologics Evaluation and Research, Food and Drug Administration.
[38 FR 32089, Nov. 20, 1973, as amended at 64 FR 26287, May 14, 1999]